CA
NZ
UK
AU
IND
US
Tiny Health has made headlines by securing the 208th spot on the 2026 Inc. 5000 list, marking it as one of America's fastest-growing private companies. This recognition is a testament to its impressive revenue growth of 1,624% from 2022 to 2025, notably outpacing many …
Charlotte's Web Holdings, Inc. (OTC: CWBHF), a leader in botanical wellness products, reported significant improvements for the second quarter of 2026. The company achieved a gross margin of 47.5% and successfully reduced operating cash use to $0.9 million. This marks a notable advancement from …
REalloys Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on August 13, 2026, covering the period ended June 30, 2026, disclosing a net loss of $143,536 thousand for the six months ended June 30, 2026.
REalloys Inc. filed a current report on August 13, 2026, disclosing the issuance of an earnings release covering its financial results for the three and six months ended June 30, 2026.
Titan Acquisition Corp filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on August 13, 2026, covering the period ended June 30, 2026.
Celcuity Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on August 13, 2026, covering the quarterly period ended June 30, 2026, and disclosing key operational and regulatory details for the commercial-stage biopharmaceutical company.
Pershing Square Inc. filed its Form 10-Q with the Securities and Exchange Commission on August 13, 2026, covering the quarterly period ended June 30, 2026.
Trailblazer Acquisition Corp. filed its quarterly report on Form 10-Q for the period ended June 30, 2026, with the U.S. Securities and Exchange Commission on August 13, 2026, disclosing its financial condition and operations as a blank-check SPAC incorporated in the Cayman Islands.
Churchill Capital Corp XI filed its quarterly report on Form 10-Q for the period ended June 30, 2026, with the SEC on August 13, 2026, disclosing financial results and details of its planned business combination with Agility Robotics, Inc.
Cellectar Biosciences, Inc. (NASDAQ: CLRB) trades with aMarket Capitalisationof $21 million and a float of 8,252,108 shares, while holding $33.99 million in cash and equivalents. At the close of the June 30, 2026 quarter the cash balance was reported at $34.0 million, reflecting a …
Please wait processing your request...